Stakeholders are closely watching to see whether FDA will cave to pressure from the White House and doctors and reinstate emergency use authorization for the anti-malarial drug hydroxychloroquine. Doctors with Detroit’s Henry Ford Health System requested FDA re-issue the EUA based on data from the health system’s observational study that suggest the drug reduced death rates in hospitalized COVID-19 patients. The agency revoked the drug’s EUA for use as a coronavirus treatment last month after data from clinical trials cast...